F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial

MLA

M. Beck, et al. F18-FDG PET/CT Imaging Early Predicts Pathologic Complete Response to Induction Chemoimmunotherapy of Locally Advanced Head and Neck Cancer: Preliminary Single-Center Analysis of the Checkrad-Cd8 Trial. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e6e2b2fd33d2874743599460a73108ea&authtype=sso&custid=ns315887.

APA

M. Beck, J. Hartwich, M. Eckstein, D. Schmidt, A. O. Gostian, S. Müller, S. Rutzner, U. S. Gaipl, J. von der Grün, T. Illmer, M. G. Hautmann, G. Klautke, J. Döscher, T. Brunner, B. Tamaskovics, A. Hartmann, H. Iro, T. Kuwert, R. Fietkau, … S. Semrau. (2022). F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial.

Chicago

M. Beck, J. Hartwich, M. Eckstein, D. Schmidt, A. O. Gostian, S. Müller, S. Rutzner, et al. 2022. “F18-FDG PET/CT Imaging Early Predicts Pathologic Complete Response to Induction Chemoimmunotherapy of Locally Advanced Head and Neck Cancer: Preliminary Single-Center Analysis of the Checkrad-Cd8 Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e6e2b2fd33d2874743599460a73108ea&authtype=sso&custid=ns315887.